10 results
DEFM14A
AGIO
Agios Pharmaceuticals Inc
11 Feb 21
Proxy related to merger
4:19pm
, as may be amended from time to time.
“Hazardous Material” means any substance, pollutant, contaminant, material or waste that is classified in any … applicable Environmental Law as “hazardous,” “toxic,” “dangerous,” a “pollutant,” a “contaminant” or words of similar meaning, including asbestos
PREM14A
AGIO
Agios Pharmaceuticals Inc
29 Jan 21
Preliminary proxy related to merger
4:22pm
for International Drug Monitoring Centre located in Uppsala Sweden, as may be amended from time to time.
“Hazardous Material” means any substance, pollutant … , contaminant, material or waste that is classified in any applicable Environmental Law as “hazardous,” “toxic,” “dangerous,” a “pollutant
DEFA14A
EX-2.1
AGIO
Agios Pharmaceuticals Inc
21 Dec 20
Additional proxy soliciting materials
9:17pm
from time to time.
“Hazardous Material” means any substance, pollutant, contaminant, material or waste that is classified in any applicable … Environmental Law as “hazardous,” “toxic,” “dangerous,” a “pollutant,” a “contaminant” or words of similar meaning, including asbestos, asbestos-containing
8-K
EX-2.1
qntph408ms 74v
21 Dec 20
Entry into a Material Definitive Agreement
9:15pm
S-3ASR
EX-1.2
ma0ov zf8
30 Apr 20
Automatic shelf registration
4:19pm
8-K
EX-1.1
9vv7be7q6z
8 Nov 19
Agios Announces Pricing of $256 Million Public Offering of Common Stock
4:57pm
8-K
EX-1.1
caarurrvt 1ir1npc
11 Dec 14
Agios Pharmaceuticals Announces Pricing of $220 Million Public Offering of Common Stock
12:00am
- Prev
- 1
- Next